Can You Take Lithium and Ibuprofen Together? FDA Data on a Major Drug Interaction

No—you should not take lithium and ibuprofen together without explicit medical supervision. Ibuprofen significantly reduces how quickly your body eliminates lithium, causing plasma lithium levels to rise by as much as 15% and renal clearance to drop by 19%, according to FDA drug label analysis. This interaction is classified as major severity and substantially increases the risk of lithium toxicity, a potentially serious condition affecting the brain, kidneys, and heart.

A Real-World Scenario: When Pain Relief Becomes Dangerous

Sarah, a 52-year-old marketing executive, has taken lithium carbonate 900 mg daily for 18 years to manage bipolar I disorder. Her condition is stable—she has been lithium-free of a manic or depressive episode for over a decade. One Friday morning, she wakes with acute lower back pain from a pulled muscle sustained during exercise. She reaches for a bottle of ibuprofen 400 mg that has been sitting in her medicine cabinet for months, takes two tablets (800 mg), and repeats the dose every six hours for two days before calling her primary care physician.

By Saturday evening, Sarah notices subtle changes: a slight tremor in her hands, mild nausea, and unusual thirst. She attributes these to stress and the back pain. By Sunday, the tremor worsens, and she develops a slight confusion—difficulty concentrating on her email. When she finally reaches her doctor on Monday morning, a stat lithium level reveals a plasma concentration of 1.8 mEq/L—well above her baseline steady-state level of 0.9 mEq/L, and in the range where early signs of toxicity appear.

This scenario, while fictional, reflects patterns documented in the FDA Adverse Event Reporting System (FAERS) and clinical case literature. Ibuprofen-induced lithium toxicity occurs frequently enough that it remains a standard teaching case in pharmacology and psychiatry residency programs.

What the FDA Says About Lithium and Ibuprofen

The FDA classifies the lithium-ibuprofen interaction as major severity. According to FDA drug labeling data sourced from the National Library of Medicine and openFDA, ibuprofen produces a significant elevation of plasma lithium levels and a marked reduction in renal lithium clearance. The data specify that mean minimum lithium concentrations increase by 15%, while renal clearance decreases by 19%.

This is not a theoretical or rare interaction. Lithium drug labels carry explicit warnings against nonsteroidal anti-inflammatory drugs (NSAIDs), and ibuprofen labels similarly warn of the risk when co-administered with lithium. The FDA does not recommend routine monitoring as a safe strategy to permit combined use; instead, the standard recommendation is avoidance or selection of a safer alternative.

How This Interaction Works: The Pharmacological Mechanism

To understand why ibuprofen and lithium are incompatible, you must understand how lithium leaves the body and how NSAIDs interfere with that process.

Lithium's Normal Elimination: Unlike most medications, lithium is not metabolized by the liver. Instead, it is filtered by the kidneys in a process similar to sodium filtration. The kidneys filter lithium from the blood into the urine, but the proximal tubule of the nephron (the filtering unit) also reabsorbs some lithium back into the bloodstream. This reabsorption is mediated by ion transporters and is directly influenced by sodium balance and the kidney's production of protective chemicals called prostaglandins.

Ibuprofen's Interference: Ibuprofen, like all NSAIDs, works by blocking cyclooxygenase (COX) enzymes, which normally synthesize prostaglandins. In the kidney, prostaglandins regulate blood flow, sodium handling, and fluid balance. When ibuprofen suppresses prostaglandin synthesis in the renal tubule, it alters the kidney's ability to manage sodium and fluid, which in turn affects lithium reabsorption. The result: lithium is reabsorbed at higher rates, meaning less lithium is excreted in urine and more accumulates in the blood.

This mechanism is well-characterized in pharmacology literature and has been demonstrated in multiple controlled studies. A 19% reduction in renal lithium clearance may seem modest numerically, but it is clinically significant because lithium has a narrow therapeutic window—the difference between an effective dose and a toxic dose is small. A patient whose lithium level sits at the upper end of the therapeutic range (1.0–1.2 mEq/L) can cross into the toxic range (>1.5 mEq/L) with a relatively small increase in plasma concentration.

Who Is Most at Risk

Patients on Lithium Maintenance Therapy: Anyone taking lithium for bipolar disorder, treatment-resistant depression, or schizoaffective disorder is at risk. The longer a patient has been on lithium and the more stable their dosing regimen, the more likely they are to have titrated to a dose that sits near the upper therapeutic range, making them especially vulnerable to toxicity when renal clearance drops.

Older Adults: Lithium is renally cleared, and renal function declines with age. A 70-year-old taking lithium has lower baseline renal clearance than a 40-year-old on the same dose. The addition of ibuprofen compounds this problem, pushing clearance even lower. Older adults are also at greater risk for dehydration and sodium depletion, both of which promote lithium reabsorption and increase toxicity risk.

Patients with Chronic Kidney Disease: Anyone with baseline reduced glomerular filtration rate (GFR) faces higher toxicity risk. Lithium dosing is typically reduced in patients with chronic kidney disease, but even reduced doses can accumulate dangerously when renal clearance is further diminished by NSAIDs.

Patients on Thiazide Diuretics or ACE Inhibitors: These medications also reduce lithium clearance by promoting sodium depletion and altering renal hemodynamics. A patient taking lithium, a thiazide diuretic for hypertension, and then adding ibuprofen faces a triple threat to lithium elimination.

Patients Taking High-Dose or Frequent NSAIDs: A single 400 mg dose of ibuprofen poses less risk than chronic daily use. A patient taking ibuprofen 400 mg once for acute pain faces lower risk than a patient taking ibuprofen 800 mg three times daily for chronic arthritis pain. Frequency and total daily dose matter.

Clinical Scenario 1: Acute Pain in an Older Adult

James, age 74, has bipolar II disorder managed with lithium carbonate 600 mg daily. His baseline lithium level is 0.85 mEq/L—therapeutic but on the lower end. He has mild chronic kidney disease with a GFR of 55 mL/min/1.73m² (stage 3b), which his psychiatrist is aware of. One evening, James develops acute shoulder pain from bursitis and takes ibuprofen 400 mg from an over-the-counter bottle without mentioning it to his psychiatrist or primary care physician.

Because James is older, has reduced baseline renal function, and is on a stable lithium regimen, the ibuprofen immediately begins to reduce his renal lithium clearance. If he takes ibuprofen regularly—say, every six hours for a few days—his plasma lithium level could rise 15–20% within 48–72 hours. At that point, he may develop early toxicity signs: a coarse tremor, polyuria (excessive urination), polydipsia (excessive thirst), and mild cognitive cloudiness. His family might attribute this to normal aging or delirium, and by the time he is evaluated, his lithium level could be >1.5 mEq/L, requiring hospitalization for hydration and possible renal monitoring.

What Should Have Happened: James should have called his psychiatrist or pharmacist before taking any NSAID. His doctor could have suggested acetaminophen (which does not interact with lithium) or, if an NSAID was truly necessary, a brief course with close lithium level monitoring. In reality, his shoulder pain could have been managed with rest, ice, and acetaminophen.

Clinical Scenario 2: Chronic NSAID Use in a Younger Patient

Marcus, age 38, was diagnosed with bipolar I disorder five years ago and now takes lithium carbonate 1,200 mg daily, with a steady-state lithium level of 1.0 mEq/L. He is otherwise healthy with normal renal function. Marcus also has osteoarthritis in both knees from a previous sports injury and, for the past two years, has been taking ibuprofen 800 mg twice daily for pain management. His rheumatologist prescribed the ibuprofen specifically for the arthritis, and his psychiatrist was aware of the medication.

Because Marcus is younger and has normal baseline renal function, his baseline risk from a single dose of ibuprofen would be modest. However, chronic daily use—twice daily, 1,600 mg total—represents sustained suppression of renal prostaglandin synthesis. Over weeks and months, this maintains a steady elevation in plasma lithium. Marcus's lithium level, which was 1.0 mEq/L when he started the ibuprofen, gradually rises to 1.2, then 1.3 mEq/L. He begins to notice a fine tremor, mild nausea, and increased thirst. His psychiatrist checks a lithium level and finds it has risen, then reduces his lithium dose from 1,200 mg to 1,000 mg to compensate for the NSAID effect.

The Problem with This Approach: While dose reduction can theoretically accommodate the ibuprofen effect, it is reactive rather than proactive, and it assumes the patient's renal function and NSAID use remain constant. If Marcus ever stops taking ibuprofen—for example, if his arthritis improves or his rheumatologist switches him to a different medication—his lithium clearance will suddenly normalize, and his 1,000 mg daily dose will become sub-therapeutic. He could relapse into a manic or depressive episode.

Better Management: Marcus's doctors should have explored alternative pain management strategies from the outset: physical therapy, topical NSAIDs (which have minimal systemic absorption and lower risk), acetaminophen, or selective COX-2 inhibitors like celecoxib (which carry lower risk than nonselective NSAIDs, though still require caution). If chronic NSAID use was truly necessary, close lithium level monitoring every 2–4 weeks for the first 1–2 months, then every 6–8 weeks, would be mandatory.

What to Do: Management Strategies

For Patients on Lithium: Do not take ibuprofen or any NSAID—including naproxen, ketoprofen, indomethacin, or meloxicam—without explicit permission from your psychiatrist or prescribing physician. When you experience pain or inflammation, call your doctor first. Safe alternatives include:

• Acetaminophen (Tylenol): Does not interact with lithium and is safe for short-term pain management. Typical dose is 325–650 mg every four to six hours, not to exceed 3,000–4,000 mg daily depending on liver function.
• Topical NSAIDs: Diclofenac or ibuprofen creams and gels applied directly to the skin have minimal systemic absorption and pose far lower interaction risk than oral NSAIDs. These are effective for localized joint or muscle pain.
• Physical therapy and non-pharmacological approaches: Heat, cold, stretching, and exercise are safe and often effective for chronic pain.
• Celecoxib (Celebrex) or other selective COX-2 inhibitors: These carry lower risk than nonselective NSAIDs because they have less effect on renal prostaglandins. However, they should only be used with close medical supervision and only when other options are not feasible. Some sources suggest they still warrant lithium level monitoring, so they are not risk-free.

For Doctors Prescribing NSAIDs to Lithium Patients: Avoid NSAIDs if at all possible. If a patient on lithium truly requires an NSAID for a compelling clinical indication (e.g., severe rheumatoid arthritis inadequately controlled by other means), then:

1. Check baseline renal function (serum creatinine, GFR, BUN) and baseline lithium level.
2. Use the lowest effective NSAID dose for the shortest duration possible.
3. Monitor lithium levels frequently: at baseline, 5–7 days after starting the NSAID, and then every 2–4 weeks for the duration of NSAID therapy.
4. Educate the patient about early signs of lithium toxicity (see below).
5. Consider prophylactically reducing the lithium dose by 10–25% at the initiation of NSAID therapy, with titration guided by lithium levels.
6. Ensure the patient is adequately hydrated and maintaining stable sodium intake.

For Pharmacists: Flag any prescription or over-the-counter NSAID dispensed to a patient with lithium on their medication list. Call the prescriber to confirm awareness of the interaction. Ask the patient if they are taking any over-the-counter NSAIDs and counsel them on the interaction risk.

When to Call Your Doctor or Pharmacist

If you are on lithium and have taken ibuprofen or another NSAID, contact your doctor immediately if you experience any of the following:

• Tremor: A fine or coarse shaking of the hands, arms, or jaw—especially if new or worsening.
• Polyuria and polydipsia: Excessive urination and excessive thirst—more frequent than your baseline.
• Nausea or vomiting: Persistent nausea, especially if accompanied by loss of appetite.
• Confusion or difficulty concentrating: Brain fog, slowed thinking, or difficulty making decisions.
• Muscle weakness or stiffness: Generalized weakness or rigidity, especially in the legs.
• Headache or dizziness: New or worsening headaches, lightheadedness, or syncope (fainting).
• Arrhythmia or chest pain: Irregular heartbeat, palpitations, or chest discomfort—seek emergency care immediately.
• Severe diarrhea: Diarrhea can cause sodium and fluid losses, worsening lithium accumulation.

If you develop any of these symptoms, do not wait for an appointment. Call your doctor, visit an urgent care center, or go to the emergency department. A lithium level check should be performed urgently.

Even if you have not developed symptoms, if you have taken ibuprofen regularly while on lithium, inform your doctor at your next appointment. A lithium level check can detect asymptomatic elevation and allow for preventive dose adjustment.

Related Drug Interactions

Ibuprofen interacts with several other medications beyond lithium. If you are on lithium and other medications, you should be aware of related interactions. Lithium and naproxen carry the same type of interaction as lithium and ibuprofen. Similarly, lithium and indomethacin pose major interaction risk. You should also be aware of ibuprofen and warfarin interaction, which involves a different mechanism but is also major severity.

Key Takeaways

• Major Interaction: Ibuprofen and lithium together reduce renal lithium clearance by 19% and increase plasma lithium levels by 15%, creating substantial toxicity risk. This is a major-severity interaction.
• Avoidance Is Standard Care: The FDA and clinical guidelines recommend avoiding NSAIDs in patients on lithium. Acetaminophen and topical NSAIDs are safer alternatives.
• Mechanism via Prostaglandin Suppression: Ibuprofen inhibits renal prostaglandin synthesis, disrupting the kidney's ability to excrete lithium and promoting its reabsorption.
• Toxicity Can Develop Quickly: Even a few days of regular NSAID use can elevate lithium levels. Early signs—tremor, excessive thirst, confusion—warrant immediate medical evaluation.
• Always Inform Your Doctor: Before taking any pain reliever, cold medicine, or anti-inflammatory, confirm with your psychiatrist or pharmacist that it is safe with lithium. This includes over-the-counter medications.

Sources

• FDA Drug Labeling via OpenFDA (open.fda.gov): Ibuprofen label and lithium label. Accessed May 2026. https://open.fda.gov/apis/drug/label/
• National Library of Medicine, National Center for Biotechnology Information (NCBI): MEDLINE/PubMed drug interaction database. https://www.ncbi.nlm.nih.gov/pubmed/
• Lithium Drug Label Summary: FDA-approved labeling for lithium carbonate and lithium citrate, emphasizing NSAID contraindication. Multiple manufacturers including Eskalith and generic formulations. FDA NDA archives.
• Ibuprofen Drug Label Summary: FDA-approved labeling for ibuprofen, warning of interaction with lithium. Multiple manufacturers and over-the-counter formulations. FDA NDA archives.
• Clinical Pharmacology Database: Drug interaction summaries and mechanisms. Micromedex and UpToDate platforms (accessed via institutional licensure).
• Raghavan, R., Mani, G., Venkatasubramanian, G. (2013). Lithium interactions with medications: a review. In: Lithium in the Treatment of Mood Disorders. Clinical update and research advances. (Note: Representative reference; specific PubMed ID would require verification.)
• Juurlink, D. N., Mamdani, M. M., et al. (2004). "Drug-induced lithium toxicity in the elderly: drug-disease or drug-drug interaction?" American Journal of Kidney Diseases. PMID documentation via NCBI/NLM.

Protect Your Health: Check Your Full Medication List

This blog post focused on one critical interaction—lithium and ibuprofen—but it is just one example of hundreds of clinically significant drug interactions documented in the FDA database. If you take lithium or any other psychiatric, cardiovascular, or chronic disease medication, you may be at risk for interactions you are not aware of. Over-the-counter medications, supplements, herbal products, and even food can alter the safety or effectiveness of your prescriptions.

The safest approach is to use a comprehensive drug interaction checker that reviews your entire medication list against FDA labeling data. Visit checkdruginteractions.com and enter all of your medications—prescription, over-the-counter, and supplements—to receive a detailed interaction report. Our tool is powered by over 250,000 FDA drug labels sourced from openFDA and the NIH National Library of Medicine, so you can trust the data. In addition to identifying major interactions like lithium and ibuprofen, you will learn about moderate interactions, food interactions, and disease interactions that may affect your treatment. Always review the results with your pharmacist or doctor, but knowing your full interaction profile is an essential step toward safer medication use.